Setrobuvir
Setrobuvir (ANA-598) is a potent, orally bioavailable non-nucleoside inhibitor of the HCV NS5B polymerase, effective in the low nanomolar range. It also demonstrates binding affinity and inhibitory activity against the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp), supporting its investigation in antiviral research for both hepatitis C and COVID-19.
Product Specifications
CAS Number
1071517-39-9
Product Name Alternative
HCVProtease, HCV Protease, HCV NS5B polymerase, DNA Synthesis, DNA/RNA Synthesis, DNASynthesis, ANA 598, ANA598, ANA-598, Setrobuvir, SARS-CoV-2, SARSCoV, RO 5466731, RO5466731, RO-5466731, RNASynthesis, RNA Synthesis, RG 7790, RG7790, RG-7790
Field of Research
Cell Biology, Infectious Disease & Virology, Molecular Biology, Protein Biochemistry
Purity
98.92% (May vary between batches)
Solubility
DMSO:252.5 mg/mL (450.39 mM)
Smiles
C (N1[C@@]2 ([C@@] ([C@@]3 (C[C@]2 (CC3) [H]) [H]) (C (O) =C (C1=O) C=4NC=5C (S (=O) (=O) N4) =CC (NS (C) (=O) =O) =CC5) [H]) [H]) C6=CC=C (F) C=C6
Molecular Formula
C25H25FN4O6S2
Molecular Weight
560.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IRBAMLACOX1AP479200UL 200 µL
Rabbit Anti ACOX1 Polyclonal Affinity Purified (PBS with 0.05% sodium azide and 50% glycerol, pH7.4) (IHC,ELISA) 200 ul
Sign In for Pricing
View Details 
